Literature DB >> 29207378

Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.

Hikmet Akkiz1, Brian I Carr, Kendal Yalçın K, Vito Guerra, Sedef Kuran, Engin Altıntaş, Oğuz Üsküdar, Ümit Karaoğullarından, Ayşegül Özakyol, Salih Tokmak, Mehmet Yücesoy, Halil İbrahim Bahçeci, Abdulalh Ülkü, Tolga Akçam, Kamil Yalçın Polat, Nazım Ekinci, Halis Şimşek, Necati Örmeci, Abdulalh Sonsuz, Mehmet Demir, Murat Kılıç, Ahmet Uygun, Tuğsan Ballı, Ali Demir, Burcu Arslan, Figen Doran.   

Abstract

A large cohort of hepatocellular carcinoma (HCC) patients from several collaborating Turkish institutions were examined for the tumor parameters of maximum diameter (MTD), portal vein thrombosis (PVT), and α-fetoprotein (AFP) levels. A relationship was found between MTD and blood platelet levels. Patients with large ≥5 cm tumors who had normal platelet levels had significantly larger tumors, higher percent of PVT, and significantly lower blood total bilirubin and liver cirrhosis than similar ≥5 cm tumor patients having thrombocytopenia. A comparison of patients with and without PVT showed significantly larger tumors, greater multifocality, blood AFP, and C-reactive protein levels, and, interestingly, lower HDL levels in the patients with PVT. Fifty-eight percent of the total cohort had AFP levels ≤100 IU/mL (and 42.1% had values ≤20 IU/mL). These patients had significantly smaller tumors, less tumor multifocality and percent PVT, lower total bilirubin, and less cirrhosis. There was considerable geographic heterogeneity within Turkey in the patterns of HCC presentation, with areas of higher and lower hepatitis B virus, hepatitis D virus, cirrhosis, and tumor aggressiveness parameters. Turkish patients thus have distinct patterns of presentation, but the biological relationships between MTD and both platelets and bilirubin levels are similar to the relationships that have been reported in other ethnic patient groups.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Aggressiveness; Albumin; Hepatocellular carcinoma; Tumor mass; Turkey; α-Fetoprotein

Mesh:

Substances:

Year:  2017        PMID: 29207378      PMCID: PMC5828952          DOI: 10.1159/000484564

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  15 in total

1.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.

Authors:  Sheng-Nan Lu; Jing-Houng Wang; Shiann-Long Liu; Chao-Hung Hung; Chien-Hung Chen; Hung-Da Tung; Tsung-Ming Chen; Wu-Shiung Huang; Chuan-Mo Lee; Chia-Cheng Chen; Chi-Sin Changchien
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

2.  The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.

Authors:  Jack P Silva; Richard A Gorman; Nicholas G Berger; Susan Tsai; Kathleen K Christians; Callisia N Clarke; Harveshp Mogal; T Clark Gamblin
Journal:  J Surg Oncol       Date:  2017-07-25       Impact factor: 3.454

Review 3.  Epidemiology, risk factors and surveillance of hepatocellular carcinoma.

Authors:  G Cabibbo; A Craxì
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

4.  Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.

Authors:  Wei-Ju Huang; Yung-Ming Jeng; Hong-Shiee Lai; Fang-Yu Bonnie Sheu; Po-Lin Lai; Ray-Hwang Yuan
Journal:  Langenbecks Arch Surg       Date:  2015-08-07       Impact factor: 3.445

5.  A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.

Authors:  Brian I Carr; Vito Guerra
Journal:  Oncology       Date:  2016-03-15       Impact factor: 2.935

6.  Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.

Authors:  Brian I Carr; Vito Guerra; Petr Pancoska
Journal:  Oncology       Date:  2012-09-18       Impact factor: 2.935

7.  HCC and its microenvironment.

Authors:  Brian I Carr; Vito Guerra
Journal:  Hepatogastroenterology       Date:  2013-09

Review 8.  Ongoing challenges in the diagnosis of hepatocellular carcinoma.

Authors:  Eleonora Terzi; Veronica Salvatore; Giulia Negrini; Fabio Piscaglia
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-19       Impact factor: 3.869

9.  A Liver Index and its Relationship to Indices of HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Alberto Masotto; Franco Trevisani
Journal:  J Integr Oncol       Date:  2016-09-05

10.  Validation and ranking of seven staging systems of hepatocellular carcinoma.

Authors:  Zhan-Hong Chen; Ying-Fen Hong; Jinxiang Lin; Xing Li; Dong-Hao Wu; Jing-Yun Wen; Jie Chen; Dan-Yun Ruan; Qu Lin; Min Dong; Li Wei; Tian-Tian Wang; Ze-Xiao Lin; Xiao-Kun Ma; Xiang-Yuan Wu; Ruihua Xu
Journal:  Oncol Lett       Date:  2017-05-22       Impact factor: 2.967

View more
  13 in total

1.  Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Seai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-10-06

2.  Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.

Authors:  H Akkiz; B I Carr; V Guerra; R Donghia; K Yalçın; U Karaoğullarından; E Altıntaş; A Özakyol; H Şimşek; H Y Balaban; A Balkan; A Uyanıkoğlu; N Ekin; A Delik
Journal:  J Transl Sci       Date:  2020-09-16

3.  Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.

Authors:  Hikmet Akkiz; Brian I Carr; Harika G Bag; Ümit Karaoğullarından; Kendal Yalçın; Nazim Ekin; Ayşegül Özakyol; Engin Altıntaş; Hatice Y Balaban; Halis Şimşek; Ahmet Uyanıkoğlu; Ayhan Balkan; Sedef Kuran; Oğuz Üsküdar; Yakup Ülger; Burak Güney; Anil Delik
Journal:  Int J Clin Pract       Date:  2020-12-12       Impact factor: 2.503

4.  Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.

Authors:  Coşkun Özer Demirtaş; Tuğba Tolu; Çaglayan Keklikkıran; Osman Cavit Özdoğan; Feyza Gündüz
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

5.  Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Volkan Ince; Sami Akbulut; Veysel Ersan; Sertac Usta; Burak Isik; Emine Samdanci; Sezai Yilmaz
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

Review 6.  Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.

Authors:  Quirino Lai; Alessandro Vitale; Tommaso M Manzia; Francesco G Foschi; Giovanni B Levi Sandri; Martina Gambato; Fabio Melandro; Francesco P Russo; Luca Miele; Luca Viganò; Patrizia Burra; Edoardo G Giannini
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

7.  Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.

Authors:  B I Carr; H Akkiz; H G Bag; U Karaoğullarından; K Yalçın; N Ekin; A Özakyol; E Altıntaş; H Y Balaban; H Şimşek; A Uyanıkoğlu; A Balkan; S Kuran; O Üsküdar; Y Ülger; B Güney; A Delik
Journal:  J Transl Sci       Date:  2020-09-17

8.  A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study.

Authors:  Giovanni Marasco; Francesco Poggioli; Antonio Colecchia; Giuseppe Cabibbo; Filippo Pelizzaro; Edoardo Giovanni Giannini; Sara Marinelli; Gian Ludovico Rapaccini; Eugenio Caturelli; Mariella Di Marco; Elisabetta Biasini; Fabio Marra; Filomena Morisco; Francesco Giuseppe Foschi; Marco Zoli; Antonio Gasbarrini; Gianluca Svegliati Baroni; Alberto Masotto; Rodolfo Sacco; Giovanni Raimondo; Francesco Azzaroli; Andrea Mega; Gianpaolo Vidili; Maurizia Rossana Brunetto; Gerardo Nardone; Luigina Vanessa Alemanni; Elton Dajti; Federico Ravaioli; Davide Festi; Franco Trevisani; On Behalf Of The Italian Liver Cancer Ita Li Ca Group
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

9.  Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.

Authors:  Aslı Suner; Brian I Carr; Hikmet Akkiz; Oguz Uskudar; Sedef Kuran; Yaman Tokat; Salih Tokmak; Tugsan Ballı; Abdulalh Ulku; Tolga AkCam; Anıl Delik; Burcu Arslan; Figen Doran; Kendal YalCın; Nazım Ekinci; Sezai Yilmaz; Ayşegul Ozakyol; Mehmet Yücesoy; Halil Ibrahim BahCeci; Kamil Yalcın Polat; Halis Şimsek; Necati Ormeci; Abdulalh Sonsuz; Mehmet Demir; Murat KılıC; Ahmet Uygun; Ali Demir; Engin Altıntas; Gokhan Karakulah; Tuncer Temel; Ahmet Bektas
Journal:  J Transl Sci       Date:  2018-06-22

10.  Safety and efficacy analysis of microwave ablation in small hepatocellular carcinomas sized below 3 cm.

Authors:  Ferhat C Piskin; Huseyin T Balli; Kairgeldy Aikimbaev
Journal:  Pol J Radiol       Date:  2020-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.